P0917n-acetyl cysteine fails to impact on plasma antioxidant capacity in both a placebo controlled crossover study and a parallel group trial of patients with ckd stage iii: implications for its use as a prophylactic for contrast induced nephropathy
Mergulhe nos tópicos de investigação de “P0917n-acetyl cysteine fails to impact on plasma antioxidant capacity in both a placebo controlled crossover study and a parallel group trial of patients with ckd stage iii: implications for its use as a prophylactic for contrast induced nephropathy“. Em conjunto formam uma impressão digital única.
Medicine and Dentistry
Nursing and Health Professions
Pharmacology, Toxicology and Pharmaceutical Science